Further studies should focus on longitudinal serum measurements and on earlier disease cohorts including patients with prodromal RBD sleep disorder, and carriers of monogenic mutations strongly implicated in PD pathogenesis, such as the glucocerebrosidase (GBA) gene. The gene discussed is GBA1; the disease is sleep disorder.